Related Experiment Videos
[Rhinocerebral mucormycosis: a case report]
C Simoncelli1, G Ricci, E Molini
1Istituto di Clinica Otorinolaringoiatrica, Università di Perugia.
Summary
Rhinocerebral mucormycosis in chronic lymphatic leukaemia patients can be successfully treated with a combined approach. This includes managing leukaemia, antifungal therapy with Amphotericin B, and surgical removal of infected tissue.
Area of Science:
- Medicine
- Infectious Diseases
- Oncology
Background:
- Rhinocerebral mucormycosis is a rare but aggressive fungal infection.
- Chronic lymphatic leukaemia (CLL) is a hematologic malignancy that can impair immune function.
- Patients with compromised immunity are at higher risk for opportunistic infections like mucormycosis.
Observation:
- A case of rhinocerebral mucormycosis in a patient with CLL is presented.
- The patient exhibited signs of orbital-cerebral involvement, typically associated with a poor prognosis.
- The presence of a hematologic malignancy like CLL complicates the management of invasive fungal infections.
Findings:
- A multi-pronged therapeutic strategy was employed, including treatment of the underlying CLL.
- Systematic antifungal treatment with Amphotericin B was administered.
- Surgical debridement of necrotic and infected tissue was performed.
Implications:
- Successful outcomes are achievable even with advanced disease and poor prognostic indicators.
- Integrated treatment addressing both the fungal infection and the underlying leukaemia is crucial.
- This case highlights the importance of prompt diagnosis and aggressive management in immunocompromised patients.